Strides Shasun receives FDA approval for Abacavir Tablets

The firm will launch the product shortly

id-10039602-1

Strides Shasun Limited has announced that it has received approval from the United States Food & Drug Administration (USFDA) for Abacavir Tablets USP, 300 mg

According to IMS data, the US market for Abacavir is approximately $30 Million.

The product will be manufactured at the Company's USFDA approved facility at Bangalore and marketed by Strides in the US Market. The product will be launched immediately.

Abacavir Tablets is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X